Harnessing mesenchymal stem cell secretome: Effect of extracellular matrices on proangiogenic signaling

Victoria Sears,Gargi Ghosh
DOI: https://doi.org/10.1002/bit.27272
IF: 3.8
2020-01-30
Biotechnology and Bioengineering
Abstract:<p>The low engraftment and retention rate of mesenchymal stem cells (MSCs) at the target site indicates that the potential benefits of MSC‐based therapies can be attributed to their paracrine signaling. In this study, the extracellular matrices (ECM) deposited by bone marrow‐derived human MSCs in the presence and absence of ascorbic acid was characterized. MSCs were seeded on top of decellularized ECM (dECM) and the concentrations of pro‐ and anti‐angiogenic molecules released in culture (conditioned) media was compared. Effects of ECM derived from MSCs with different passage numbers on MSC secretome was also investigated. Our study revealed that the expression of pro‐angiogenesis‐related factors were upregulated when MSCs were harvested on dECMs, irrespective of media supplementation, as compared to those cultured on tissue culture plates. In addition, dECM generated in presence of ascorbic acid promoted expression of pro‐angiogenic molecules as compared to dECM derived in absence of media supplementation. Further, it was observed that the effectiveness of dECM to stimulate pro‐angiogenic signaling of MSCs was reduced as cell passage number was increased from P3 to P5. The proliferation as well as capillary morphogenesis of human umbilical vein endothelial cells (HUVECs) in the presence of conditioned media were enhanced compared to the normal HUVECs culture media. These data indicate that the secretory signatures of MSCs and consequently, the therapeutic efficacy of MSCs can be regulated by presentation of dECM composition and variation of its composition.</p><p>This article is protected by copyright. All rights reserved.</p>
biotechnology & applied microbiology
What problem does this paper attempt to address?